ADC Therapeutics SA (NASDAQ:ADCT) filed a Form 8-K with the Securities and Exchange Commission on January 08, 2026, disclosing a material event.
ADC Therapeutics SA's stock currently trades at $0.00 with a market capitalization of $0. The company's stock moved following the disclosure.